GB:0R44 Stock Latest News
Company AnnouncementsC-Rad Wins 8 MSEK SGRT Deal, Bolsters U.S. Northeast Presence4d ago
Company AnnouncementsC-Rad Navigates Soft Demand With Stronger Margins and Radiotherapy Portfolio1w ago
Company AnnouncementsC-RAD Launches Share Buyback to Tighten Capital Structure and Support Growth Targets1w ago
Pre-Earnings24C Earnings this Week: How Will it Perform?1w ago
Company AnnouncementsC-RAD Sets October 22 Presentation for Q3 2026 Interim Report3w ago
Company AnnouncementsC-RAD and SeeTreat Join Forces to Build Integrated Adaptive Radiotherapy Platform1M ago
- Pre-Earnings24C Earnings Report this Week: Is It a Buy, Ahead of Earnings?3M ago
Company AnnouncementsC-Rad and SeeTreat Forge Alliance to Advance Personalised Radiotherapy Workflows5M ago
Company AnnouncementsC-RAD Unveils Clinician-Led SGRT Enhancements and New Modular System at ESTRO 20265M ago
Company AnnouncementsC-RAD Launches Transformation Drive as Q1 Shows Strong Orders but Weaker Revenue5M ago
Company AnnouncementsC-RAD Targets Profitable Growth as Demand for Advanced Radiotherapy Solutions Rises6M ago
Company AnnouncementsC-RAD Names Former Biotage Chief Tomas Blomquist as CEO to Drive Next Growth Phase9M ago- Company AnnouncementsC-RAD AB Announces Share Repurchase Program to Optimize Capital Structure1y ago
Company AnnouncementsC-RAD AB Reports Strong Q3 2025 Earnings and Strategic Growth Initiatives1y ago- Company AnnouncementsC-RAD Announces Leadership Transition with New Acting CEO1y ago
Company AnnouncementsC-RAD Expedites Q3 2025 Interim Report Approval1y ago
